Literature DB >> 11971944

Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II.

Elisabeth Boisfer1, Dominique Stengel, Danièle Pastier, P Michel Laplaud, Nicole Dousset, Ewa Ninio, Athina-Despina Kalopissis.   

Abstract

Transgenic mice overexpressing human apolipoprotein A-II (huapoA-II) display high VLDL and low HDL levels. To evaluate the antioxidant potential of huapoA-II enriched HDL, we measured the activities of paraoxonase (PON) and platelet-activating factor acetylhydrolase (PAF-AH). Both activities decreased up to 43% in the serum of transgenic mice compared with controls, varied in parallel to HDL levels, but decreased less than HDL levels. The major part of PON and PAF-AH was associated with HDL, except in fed high huapoA-II-expressing mice, in which 20% of PAF-AH and 9% of PON activities were associated with VLDL. PON mRNA levels in the liver, its major site of synthesis, were similar in transgenic and control animals, indicating normal enzyme synthesis. In transgenic mice, the basal oxidation of lipoproteins was not increased, whereas their VLDL were more susceptible to oxidation than VLDL of controls. Interestingly, HDL of transgenic mice protected VLDL from oxidation more efficiently than HDL of controls. In conclusion, the decrease in both PON and PAF-AH activities in huapoA-II transgenic mice is best explained by their lower plasma HDL levels. However, the unchanged basal lipoprotein oxidation in transgenic mice suggests that huapoA-II-rich HDL may maintain adequate antioxidant potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971944

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

Review 2.  HDL therapy for cardiovascular diseases: the road to HDL mimetics.

Authors:  C Roger White; Geeta Datta; Zhenghao Zhang; Himanshu Gupta; David W Garber; Vinod K Mishra; Mayakonda N Palgunachari; Shaila P Handattu; Manjula Chaddha; G M Anantharamaiah
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 3.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

4.  Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis.

Authors:  Andrea Rivas-Urbina; Noemi Rotllan; David Santos; Josep Julve; Joan Carles Escolà-Gil; Jose Luis Sanchez-Quesada
Journal:  Methods Mol Biol       Date:  2022

5.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01

6.  Relationship between concentration difference of different density lipoproteins and shear stress in atherosclerosis.

Authors:  Wei Meng; Fengxu Yu; Huaiqing Chen; Jianmin Zhang; Eryong Zhang; Yingqiang Guo; Yingkang Shi
Journal:  Comput Math Methods Med       Date:  2012-03-07       Impact factor: 2.238

7.  Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.

Authors:  James P Corsetti; Stephan J L Bakker; Charles E Sparks; Robin P F Dullaart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 8.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.

Authors:  Fernando Brites; Maximiliano Martin; Isabelle Guillas; Anatol Kontush
Journal:  BBA Clin       Date:  2017-08-19

9.  Concentration polarization of high-density lipoprotein and its relation with shear stress in an in vitro model.

Authors:  Wei Meng; Fengxu Yu; Huaiqing Chen; Jianmin Zhang; Eryong Zhang; Ke Dian; Yingkang Shi
Journal:  J Biomed Biotechnol       Date:  2009-09-10

10.  Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction.

Authors:  Manoj Sigdel; Binod Kumar Yadav; Prajwal Gyawali; Prashant Regmi; Sushil Baral; Shyam Raj Regmi; Bharat Jha
Journal:  BMC Res Notes       Date:  2012-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.